Literature DB >> 8116226

Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis.

A D Danon1, J Krishnan, G Frizzera.   

Abstract

A histologic review of 102 cases of Castleman's disease of the hyaline-vascular type, with a detailed paraffin immunophenotypic study of 23 of them, was undertaken to evaluate the morphologic variability of this disorder and its immuno/cyto-architectural characteristics. All cases had features in common including: abnormal follicles, with increased vascularity, poorly formed germinal centers and predominance of the mantle zone; lack of sinuses; and hypervascular interfollicular tissue containing large numbers of KP1-positive plasmacytoid monocytes. Networks of actin-positive cells [fibroblastic reticulum cells (RCs) or "myoid cells"] and KP1-positive dendritic cells (histiocytic RCs) were seen. There were differences in the proportion of follicles to interfollicular tissue, which covered a continuum from a "follicular", through a "classic", to a "stroma-rich" variant. The last-mentioned was qualitatively different as it showed loss of HECA-452 and MECA-79 reactivity in the blood vessels, decreased plasmacytoid monocytes and increased myoid cells and histiocytic RCs. In 5 cases there was formation of distinct nodular growths which varied from spindle cell foci to angio-histiocytic-RC proliferations, all of which may be confused with vascular or follicular dendritic RC neoplasms. From our findings, data from the literature and the working hypothesis that plasmacytoid monocytes are the precursors of both follicular dendritic RCs and sinus lining cells (Parwaresch et al.), a pathogenetic theory is proposed for this type of Castleman's disease which postulates that a developmental block in plasmacytoid monocytes results in their accumulation with poor formation of germinal centers and sinuses under stimulation. The lack of sinuses would lead to impaired egress of circulating lymphocytes which, however, would continue to enter the node through functional high endothelial venules and to accumulate in the mantle zone. The factors responsible for angiogenesis and for the cellular growths that characterize the stroma-rich variant remain to be determined, as do the relationships between the three variants.

Entities:  

Mesh:

Year:  1993        PMID: 8116226     DOI: 10.1007/bf01607150

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  38 in total

1.  Lymphnodal hamartoma versus thymic choristoma of pulmonary hilum.

Authors:  M R ABELL
Journal:  AMA Arch Pathol       Date:  1957-11

2.  Giant lymph node hyperplasia of the hyaline vascular type with plasmacytoid T-cells and presentation in infancy.

Authors:  S J Hunt; W D Anderson
Journal:  Am J Clin Pathol       Date:  1989-03       Impact factor: 2.493

3.  Mesenteric lymphoid hamartoma associated with chronic hypoferremia, anemia, growth failure and hyperglobulinemia.

Authors:  R C Neerhout; W Larson; P Mansur
Journal:  N Engl J Med       Date:  1969-04-24       Impact factor: 91.245

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 5.  Anatomy and histophysiology of lymphoid tissue.

Authors:  C De Wolf-Peeters; J Delabie
Journal:  Semin Oncol       Date:  1993-12       Impact factor: 4.929

6.  Fibroblastic and dendritic reticulum cells of lymphoid tissue. Ultrastructural, histochemical, and 3H-thymidine labeling studies.

Authors:  H K Müller-Hermelink; B von Gaudecker; D Drenckhahn; K Jaworsky; C Feldmann
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

7.  Angiomatous lymphoid hamartoma. Report of five cases with a review of the literature.

Authors:  K S Tung; L J McCormack
Journal:  Cancer       Date:  1967-04       Impact factor: 6.860

8.  Vimentin immunostaining in fibroblastic reticulum cells within human reactive and neoplastic lymphoid follicles.

Authors:  A Gloghini; R Volpe; A Carbone
Journal:  Hum Pathol       Date:  1990-08       Impact factor: 3.466

9.  Interleukin-6 gene expression in Castleman's disease.

Authors:  M B Leger-Ravet; M Peuchmaur; O Devergne; J Audouin; M Raphael; J Van Damme; P Galanaud; J Diebold; D Emilie
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

10.  S-100 beta positive human T lymphocytes: their characteristics and behavior under normal and pathologic conditions.

Authors:  K Takahashi; T Yoshino; K Hayashi; H Sonobe; Y Ohtsuki
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

View more
  12 in total

Review 1.  The plasmacytoid monocyte/interferon producing cells.

Authors:  Fabio Facchetti; William Vermi; David Mason; Marco Colonna
Journal:  Virchows Arch       Date:  2003-10-28       Impact factor: 4.064

2.  A rare stroma-rich variant of hyaline-vascular Castleman's disease associated with calcifying fibrous pseudotumor.

Authors:  Haifen Ma; Maofen Jiang; Weihua Xiao
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 3.  Clinical features and outcome of patients with HIV-negative multicentric Castleman's disease treated with combination chemotherapy: a report on 10 patients.

Authors:  Shou-Hui Zhu; Yong-Hua Yu; Yong Zhang; Ju-Jie Sun; Da-Li Han; Jia Li
Journal:  Med Oncol       Date:  2013-02-12       Impact factor: 3.064

4.  Histomorphologic Spectrum in Hyaline Vascular Variant of Castleman Disease.

Authors:  Chaithra Gowthuvalli Venkataramana; Hema Kini; Debarshi Saha; Sharada Rai; Deepa Sowkur Anandarama Adiga; Ranjitha Rao; Cheryl Sarah Philipose
Journal:  J Clin Diagn Res       Date:  2017-08-01

5.  Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?

Authors:  J O'Leary; M Kennedy; D Howells; I Silva; V Uhlmann; K Luttich; S Biddolph; S Lucas; J Russell; N Bermingham; M O'Donovan; M Ring; C Kenny; M Sweeney; O Sheils; C Martin; S Picton; K Gatter
Journal:  Mol Pathol       Date:  2000-04

6.  Imaging findings of Castleman's disease localized in the axilla: a case report.

Authors:  Bo Kyoung Seo; Yu Whan Oh; Kyu Ran Cho; Nam Joon Lee; Jung Hyuk Kim; In Sun Kim; Seong Jin Cho; Jeoung Won Bae
Journal:  Korean J Radiol       Date:  2002 Apr-Jun       Impact factor: 3.500

7.  Intrapulmonary Castleman's Disease Pretending to Be a Lung Cancer-Work Up of an Intrapulmonary Tumour.

Authors:  Benedikt Haager; Gian Kayser; Severin Schmid; Bernward Passlick; Sebastian Wiesemann
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-11-19       Impact factor: 1.520

8.  Castleman's disease - a diagnostic dilemma.

Authors:  Anupama Barua; Kostas Vachlas; Richard Milton; James Andrew Charles Thorpe
Journal:  J Cardiothorac Surg       Date:  2014-11-28       Impact factor: 1.637

Review 9.  Recurrence in unicentric castleman's disease postoperatively: a case report and literature review.

Authors:  Na Ren; Lei Ding; Erna Jia; Jinru Xue
Journal:  BMC Surg       Date:  2018-01-04       Impact factor: 2.102

10.  Calcified fibrous pseudotumor with Castleman disease.

Authors:  İsmail Harmankaya; Nevzat Serdar Ugras; Tamer Sekmenli; Fatih Demir; Yavuz Köksal
Journal:  Autops Case Rep       Date:  2018-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.